ClinicalTrials.Veeva

Menu

Stellate Ganglion Block

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status and phase

Enrolling
Phase 4

Conditions

Esophagectomy
Pneumonectomy
Lobectomy

Treatments

Drug: 0.5% bupivacaine
Other: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT06271707
ANES-2024-32720

Details and patient eligibility

About

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Enrollment

48 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.

Exclusion criteria

  • Patients who have an exclusion to regional anesthesia.
  • Patients who have exclusion to stellate blockade.
  • Patients who are pregnant assessed via self-report or pregnancy test if they have taken one

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

48 participants in 2 patient groups

Group 1
Experimental group
Description:
ultrasound with bupivacaine
Treatment:
Drug: 0.5% bupivacaine
Group 2
Sham Comparator group
Description:
Ultrasound with saline
Treatment:
Other: Saline

Trial contacts and locations

1

Loading...

Central trial contact

Candace Nelson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems